Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Talk:MitObesity drugs"

From Bioblast
Line 2: Line 2:
::::* https://academic.oup.com/function/article/2/6/zqab045/6362606?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6
::::* https://academic.oup.com/function/article/2/6/zqab045/6362606?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6
::::* https://academic.oup.com/function/article/2/6/zqab057/6423774?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6
::::* https://academic.oup.com/function/article/2/6/zqab057/6423774?utm_source=APS&utm_medium=email&utm_campaign=etoc-vol2iss6
::::* https://journals.physiology.org/doi/abs/10.1152/ajpendo.00293.2021?utm_source=APSselect&utm_medium=email&utm_campaign=july2022&_zs=XShbW&_zl=LtCA3

Revision as of 15:47, 2 July 2022